Table 1. Patients' characteristics.
| Parameter | N or mean (s.d.) |
|---|---|
| Total number of patients enrolled | 88 |
| Age at diagnosis (years) | 49.9 (14.1) |
| Histological type | |
| Squamous cell carcinoma | 71 (80.7%) |
| Adenocarcinoma | 12 (13.6%) |
| Adenosquamous carcinoma | 5 (5.7%) |
| Tumour stage | |
| FIGO IB1 | 20 (22.7%) |
| FIGO IB2 | 10 (11.4%) |
| FIGO IIA | 7 (8.0%) |
| FIGO IIB | 38 (43.2%) |
| FIGO IIIA | 2 (2.3%) |
| FIGO IIIB | 9 (10.2%) |
| FIGO IVA | 2 (2.2%) |
| Parametrial involvement | |
| Negative | 39 (44.3%) |
| Positive | 49 (55.7%) |
| Histological grade | |
| G1 | 7 (8.0%) |
| G2 | 49 (55.7%) |
| G3 | 32 (36.3%) |
| Recurrence status | |
| No. of patients with recurrent disease | 40 (45.5%) |
| Mean time to recurrent disease (months) | 18.9 (16.9) |
| Status at last observation | |
| Alive with no evidence of disease or stable disease | 46 (52.3%) |
| Progressive disease | 4 (4.5%) |
| Tumour-related death | 34 (38.6%) |
| Dead as a result of other causes | 4 (4.5%) |
Abbreviations: FIGO=International Federation of Gynecologists and Obstetricians; s.d.=standard deviation.